40 related articles for article (PubMed ID: 2453564)
21. Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.
Press OW; Martin PJ; Thorpe PE; Vitetta ES
J Immunol; 1988 Dec; 141(12):4410-7. PubMed ID: 2461993
[TBL] [Abstract][Full Text] [Related]
22. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
Ito T; Qiu H; Collins JA; Brill AB; Johnson DK; Griffin TW
Cancer Res; 1991 Jan; 51(1):255-60. PubMed ID: 1988087
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
Griffin TW; Childs LR; FitzGerald DJ; Levin LV
J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of ricin A chain-containing immunotoxins directed against different epitopes on the delta-chain of cell surface-associated IgD on murine B cells.
May RD; Finkelman FD; Wheeler HT; Uhr JW; Vitetta ES
J Immunol; 1990 May; 144(9):3637-42. PubMed ID: 1691764
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
[TBL] [Abstract][Full Text] [Related]
26. Complementarity, specificity and the nature of epitopes and paratopes in multivalent interactions.
Greenspan NS; Cooper LJ
Immunol Today; 1995 May; 16(5):226-30. PubMed ID: 7540013
[TBL] [Abstract][Full Text] [Related]
27. Antibody multivalency effects in the direct binding model for vesicle immunolysis assays.
Waite BA; Chang EL
J Immunol Methods; 1988 Dec; 115(2):227-38. PubMed ID: 3058807
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.
Byers VS; Pawluczyk I; Berry N; Durrant L; Robins RA; Garnett MC; Price MR; Baldwin RW
J Immunol; 1988 Jun; 140(11):4050-5. PubMed ID: 2453564
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody targeting of anti-cancer agents: Mühlbock memorial lecture.
Baldwin RW
Eur J Cancer Clin Oncol; 1985 Nov; 21(11):1281-5. PubMed ID: 3908118
[No Abstract] [Full Text] [Related]
30. Immunoassays for carcinoembryonic antigen: specificity and interferences.
Børmer OP
Scand J Clin Lab Invest; 1993 Feb; 53(1):1-9. PubMed ID: 7680822
[No Abstract] [Full Text] [Related]
31. Antibody mediated delivery of toxic molecules to antigen bearing target cells.
Raso V
Immunol Rev; 1982; 62():93-117. PubMed ID: 6210622
[No Abstract] [Full Text] [Related]
32. Structural factors influencing the pharmacokinetics and stability of immunotoxins.
Wawrzynczak EJ; Cumber AJ; Henry RV; Parnell GD; Westwood JH
Biochem Soc Trans; 1992 Nov; 20(4):738-43. PubMed ID: 1487053
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
